Your browser doesn't support javascript.
loading
Recounting the FANTOM CAGE-Associated Transcriptome.
Imada, Eddie Luidy; Sanchez, Diego Fernando; Collado-Torres, Leonardo; Wilks, Christopher; Matam, Tejasvi; Dinalankara, Wikum; Stupnikov, Aleksey; Lobo-Pereira, Francisco; Yip, Chi-Wai; Yasuzawa, Kayoko; Kondo, Naoto; Itoh, Masayoshi; Suzuki, Harukazu; Kasukawa, Takeya; Hon, Chung-Chau; de Hoon, Michiel J L; Shin, Jay W; Carninci, Piero; Jaffe, Andrew E; Leek, Jeffrey T; Favorov, Alexander; Franco, Gloria R; Langmead, Ben; Marchionni, Luigi.
Afiliación
  • Imada EL; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
  • Sanchez DF; Departamento de Bioqúimica e Imunologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Collado-Torres L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
  • Wilks C; Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA.
  • Matam T; Department of Computer Science, Johns Hopkins University, Baltimore, Maryland 21218, USA.
  • Dinalankara W; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
  • Stupnikov A; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
  • Lobo-Pereira F; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
  • Yip CW; Departamento de Biologia General, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Yasuzawa K; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Kondo N; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Itoh M; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Suzuki H; RIKEN, Preventive Medicine and Diagnostic Innovation Program, Yokohama, 351-0198, Japan.
  • Kasukawa T; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Hon CC; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • de Hoon MJL; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Shin JW; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Carninci P; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Jaffe AE; RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
  • Leek JT; Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA.
  • Favorov A; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.
  • Franco GR; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.
  • Langmead B; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.
  • Marchionni L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21827, USA.
Genome Res ; 30(7): 1073-1081, 2020 07.
Article en En | MEDLINE | ID: mdl-32079618
ABSTRACT
Long noncoding RNAs (lncRNAs) have emerged as key coordinators of biological and cellular processes. Characterizing lncRNA expression across cells and tissues is key to understanding their role in determining phenotypes, including human diseases. We present here FC-R2, a comprehensive expression atlas across a broadly defined human transcriptome, inclusive of over 109,000 coding and noncoding genes, as described in the FANTOM CAGE-Associated Transcriptome (FANTOM-CAT) study. This atlas greatly extends the gene annotation used in the original recount2 resource. We demonstrate the utility of the FC-R2 atlas by reproducing key findings from published large studies and by generating new results across normal and diseased human samples. In particular, we (a) identify tissue-specific transcription profiles for distinct classes of coding and noncoding genes, (b) perform differential expression analysis across thirteen cancer types, identifying novel noncoding genes potentially involved in tumor pathogenesis and progression, and (c) confirm the prognostic value for several enhancer lncRNAs expression in cancer. Our resource is instrumental for the systematic molecular characterization of lncRNA by the FANTOM6 Consortium. In conclusion, comprised of over 70,000 samples, the FC-R2 atlas will empower other researchers to investigate functions and biological roles of both known coding genes and novel lncRNAs.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transcriptoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Genome Res Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Transcriptoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Genome Res Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos